Edelman's solution-based advice on regaining trust in healthcare and how it got lost in the first place.
Strategies to accelerate the shift from volume to value
We reviewed the approaches State legislators took to offset the effect of defunding CSRs. Here are our observations of activity across the country.
Why a focus on the provider is needed to achieve 4 or 5 Stars.
Our new advice for the Blues, who are in a formative period as market trends create both sizable risk and sizable opportunity.
Advice on how the healthcare industry can address the pharmaceutical cost problem.
Why are premiums rising amidst the Affordable Care Act market? It's not because of medical trends, says Oliver Wyman's 2018 Carrier Trend Survey.
Adaptability is key for the future healthcare workforce. But those organizations interested in outsourcing their talent need these strategic tools to remain competitive.
Pregnant women are often positioned with taking care of themselves independently in between physician visits. Here's how a new support system empowers women's health.
Here’s more on how proposed modifications to CMS’ Advance Notice Summary may affect reimbursement, payment growth rates, and regulation.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.